Pöördumine

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE WELTGESUNDHEITSORGANISATION REGIONALBÜRO FÜR EUROPA

ORGANISATION MONDIALE DE LA SANTÉ BUREAU RÉGIONAL DE L'EUROPE

ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Assessing progress towards the global diabetes targets in WHO European region (second session)

/4

Online via zoom Issue date: 30/5/2024 Tuesday 9th July 10:30-12:00 CET Original: English

Provisional programme

10:15–10:30 Technical checks for speakers

10:30–10:35 Opening

 Welcome and introductions

10:35–10:50 Background and context

 Briefing on policy context and purpose of initiative

 This presentation will introduce the strategic context for the global diabetes targets, alongside the WHO/Europe initiative and rationale. This will include a summary of current progress against the targets in WHO Europe, and current limitations.

10:50–11:10 Measuring the global diabetes targets

 WHO Europe perspective

 This presentation will provide a EURO perspective on the data sources and approaches that could be used to measure targets across the region, alongside strengths and limitations.

 National perspectives Examples from countries

 This presentation will provide country examples on how the five diabetes targets could be measured in specific national contexts, alongside strengths and limitations.

Questions and answers

11:10–11:50 Towards a European picture of the diabetes targets

 Guided discussions

 Guided discussions will provide an opportunity to discuss reflections on how to measure the targets in different country settings, and future involvement in the WHO/Europe initiative.

11:50–11:55 Summary of discussions

11:55–12:00 Next steps and close of meeting

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE WELTGESUNDHEITSORGANISATION REGIONALBÜRO FÜR EUROPA

ORGANISATION MONDIALE DE LA SANTÉ BUREAU RÉGIONAL DE L'EUROPE

ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Assessing progress towards the global diabetes targets in WHO European region

Issue date: 30/05/2024 Original: English

Scope and purpose

The epidemic of diabetes continues to increase in the WHO European region; according to International Diabetes Federation estimates, one third remains undiagnosed and up to half may not meet their treatment targets. Five global diabetes coverage targets were adopted at the seventy-fifth World Health Assembly (WHA), which were developed following the seventy-fourth WHA resolution 74.4 on reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. The five new targets set the standard that, by 2030: 80% of people with diabetes are diagnosed; 80% of people with diagnosed diabetes have good control of glycaemia; 80% of people with diagnosed diabetes have good control of blood pressure; 60% of people with diabetes of 40 years or older receive statins; and, 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring. The targets complement the wider noncommunicable disease agenda, supporting achievement of the 2030 Agenda for Sustainable Development, and the global and European action plans for the prevention and control of noncommunicable diseases. Additionally, the targets specifically support the 2021 WHO Global Diabetes Compact initiative. In November 2023, WHO Regional Office for Europe (WHO/Europe) and International Diabetes Federation Europe held a high-level technical summit to accelerate commitments on diabetes across the WHO European region. During the summit, WHO/Europe presented an update of progress towards the diabetes targets, which highlighted two key issues. Firstly, there are apparently significant data gaps for the Region, for some targets more than others. Secondly, the current picture of progress suggests significant gaps in outcomes, with few Member States achieving any target. Overall, there is currently not a clear picture of progress against the diabetes targets in the WHO European region, and possibly also at national level. WHO/Europe have embarked on an initiative in 2024 to get a more robust assessment of performance against the global diabetes targets across the WHO European region. A more robust picture will ultimately help to identify gaps and support targeted action to improve outcomes for individuals with diabetes across the region, contributing to wider noncommunicable disease targets. The WHO/Europe initiative has firstly involved collaboration with technical experts to determine different approaches for how the targets can be measured across the region and within countries. Subsequently, WHO/Europe will work with several Member States to assess the targets within their country. Finally, WHO/Europe will create a summary brief to share learning across the region on how targets can be measured at the national level, and across the Region using varied case-studies from Member States. As part of the initiative, WHO/Europe are holding a series of online meetings to bring together representatives from Member States, aiming to help build a picture of how the targets can be measured within countries. The first meeting took place on 13 May 2024 with the second scheduled for 9 July 2024, and a further one to two meetings to follow by end 2024. The objectives of these meetings include to familiarise Member States with the global targets, discuss different approaches for how the targets can be

Scope and purpose page 2 measured through examples from different national contexts, and facilitate discussion on key considerations in assessing the targets in-country. Interested Member States may wish to follow up within their country and/or with WHO/Europe to gather good practice on how to measure the targets. The meetings are for invited participants only.

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE WELTGESUNDHEITSORGANISATION REGIONALBÜRO FÜR EUROPA

ORGANISATION MONDIALE DE LA SANTÉ BUREAU RÉGIONAL DE L'EUROPE

ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Assessing progress towards the global diabetes targets in WHO European region (second session)

/4

Online via zoom Issue date: 30/5/2024 Tuesday 9th July 10:30-12:00 CET Original: English

Provisional programme

10:15–10:30 Technical checks for speakers

10:30–10:35 Opening

 Welcome and introductions

10:35–10:50 Background and context

 Briefing on policy context and purpose of initiative

 This presentation will introduce the strategic context for the global diabetes targets, alongside the WHO/Europe initiative and rationale. This will include a summary of current progress against the targets in WHO Europe, and current limitations.

10:50–11:10 Measuring the global diabetes targets

 WHO Europe perspective

 This presentation will provide a EURO perspective on the data sources and approaches that could be used to measure targets across the region, alongside strengths and limitations.

 National perspectives Examples from countries

 This presentation will provide country examples on how the five diabetes targets could be measured in specific national contexts, alongside strengths and limitations.

Questions and answers

11:10–11:50 Towards a European picture of the diabetes targets

 Guided discussions

 Guided discussions will provide an opportunity to discuss reflections on how to measure the targets in different country settings, and future involvement in the WHO/Europe initiative.

11:50–11:55 Summary of discussions

11:55–12:00 Next steps and close of meeting

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE WELTGESUNDHEITSORGANISATION REGIONALBÜRO FÜR EUROPA

ORGANISATION MONDIALE DE LA SANTÉ BUREAU RÉGIONAL DE L'EUROPE

ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Assessing progress towards the global diabetes targets in WHO European region

Issue date: 30/05/2024 Original: English

Scope and purpose

The epidemic of diabetes continues to increase in the WHO European region; according to International Diabetes Federation estimates, one third remains undiagnosed and up to half may not meet their treatment targets. Five global diabetes coverage targets were adopted at the seventy-fifth World Health Assembly (WHA), which were developed following the seventy-fourth WHA resolution 74.4 on reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. The five new targets set the standard that, by 2030: 80% of people with diabetes are diagnosed; 80% of people with diagnosed diabetes have good control of glycaemia; 80% of people with diagnosed diabetes have good control of blood pressure; 60% of people with diabetes of 40 years or older receive statins; and, 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring. The targets complement the wider noncommunicable disease agenda, supporting achievement of the 2030 Agenda for Sustainable Development, and the global and European action plans for the prevention and control of noncommunicable diseases. Additionally, the targets specifically support the 2021 WHO Global Diabetes Compact initiative. In November 2023, WHO Regional Office for Europe (WHO/Europe) and International Diabetes Federation Europe held a high-level technical summit to accelerate commitments on diabetes across the WHO European region. During the summit, WHO/Europe presented an update of progress towards the diabetes targets, which highlighted two key issues. Firstly, there are apparently significant data gaps for the Region, for some targets more than others. Secondly, the current picture of progress suggests significant gaps in outcomes, with few Member States achieving any target. Overall, there is currently not a clear picture of progress against the diabetes targets in the WHO European region, and possibly also at national level. WHO/Europe have embarked on an initiative in 2024 to get a more robust assessment of performance against the global diabetes targets across the WHO European region. A more robust picture will ultimately help to identify gaps and support targeted action to improve outcomes for individuals with diabetes across the region, contributing to wider noncommunicable disease targets. The WHO/Europe initiative has firstly involved collaboration with technical experts to determine different approaches for how the targets can be measured across the region and within countries. Subsequently, WHO/Europe will work with several Member States to assess the targets within their country. Finally, WHO/Europe will create a summary brief to share learning across the region on how targets can be measured at the national level, and across the Region using varied case-studies from Member States. As part of the initiative, WHO/Europe are holding a series of online meetings to bring together representatives from Member States, aiming to help build a picture of how the targets can be measured within countries. The first meeting took place on 13 May 2024 with the second scheduled for 9 July 2024, and a further one to two meetings to follow by end 2024. The objectives of these meetings include to familiarise Member States with the global targets, discuss different approaches for how the targets can be

Scope and purpose page 2 measured through examples from different national contexts, and facilitate discussion on key considerations in assessing the targets in-country. Interested Member States may wish to follow up within their country and/or with WHO/Europe to gather good practice on how to measure the targets. The meetings are for invited participants only.

UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email: [email protected] DK-2100 Copenhagen Ø Denmark

Fax: +45 45 33 70 01 Website: https://www.who.int/europe

WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ

WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

Date: 31 May 2024 Ms Helen Sõber Adviser European Union Affairs and International Co- operation Department Ministry of Social Affairs Suur-Ameerika 1 10122 Tallinn Estonia

REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L’EUROPE

REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Head office:

UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark

Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01 Email: [email protected]

Website: https://www.who.int/europe

Our reference: Notre référence: Unser Zeichen: См. наш номер:

Your reference: Votre référence: Ihr Zeichen: На Ваш номер:

Dear Ms Sõber,

Assessing progress towards the global diabetes targets in the WHO European region

I have the honour to inform you that the WHO Regional Office for Europe has started the above- mentioned initiative, which includes a number of meetings. Diabetes is one of the most common chronic conditions in Europe. At least 64 million adults and around 300 000 children and adolescents are estimated to be living with diabetes in the WHO European Region. Furthermore, according to International Diabetes Federation estimates, one third remains undiagnosed and up to half may not meet their treatment targets. Five global diabetes coverage targets were adopted at the seventy-fifth World Health Assembly (WHA), which were developed following the seventy-fourth WHA resolution 74.4 on reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. The five new targets set the standard that, by 2030: 80% of people with diabetes are diagnosed; 80% of people with diagnosed diabetes have good control of glycaemia; 80% of people with diagnosed diabetes have good control of blood pressure; 60% of people with diabetes of 40 years or older receive statins; and 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring. The targets complement the wider noncommunicable disease agenda, supporting achievement of the 2030 Agenda for Sustainable Development, and the global and European action plans for the prevention and control of noncommunicable diseases. Additionally, the targets specifically support the 2021 WHO Global Diabetes Compact initiative. However, there is currently not a clear picture of progress against the diabetes targets in the WHO European Region, and possibly also at national level. To support Member States, WHO Regional Office for Europe is launching an initiative to get a more robust assessment of progress against the global diabetes targets in the WHO European Region and in- country. Assessment of the global diabetes targets across the Region can help to support targeted action, reduce disparities, and improve outcomes for those living with diabetes. Further detail on the initiative is available in the attached scope and purpose.

– 2 –

WHO held the first regional online technical workshop on Monday 13th May and you were invited to nominate participants to attend. The workshop aimed to help build a picture of how the targets can be measured within countries, specifically through sharing examples from different national contexts. Follow-up online meetings will be arranged throughout the year to allow as many countries as possible to participate. The second online meeting is scheduled for Tuesday 9th July 2024, and a further one to two meetings to follow by the end of 2024. The working languages will be English and Russian, and simultaneous interpretation will be provided. As we did not already hear from you, we wonder if you would still be interested to provide nominations of two participants for this initiative and the related meetings. You may wish to consider the following as participants:

 Leaders working in diabetes, such as chief endocrinologists or heads of national diabetes programmes;

 Technical experts working in non-communicable disease surveillance, eHealth or diabetes registers.

I would be grateful if you could share the contact details (name, functional title, and email address) of the nominated representatives by 30 June 2024. Please send the nominations by email to Anita Strandsbjerg ([email protected]). For questions about the workshop please contact Dr Jill Farrington, Regional Medical Officer, Cardiovascular Disease and Diabetes ([email protected]). Sincerely yours,

Dr Gauden Galea Strategic Adviser to the Regional Director Special Initiative on NCDs and Innovation Encls: Provisional programme Scope and purpose Copy for information to: Ms Triin Uusberg, Head, European Union Affairs and International Co-operation Department, Ministry of Social Affairs, Suur-Ameerika 1, 10129 Tallinn, Estonia H.E. Ms Riia Salsa-Audiffren, Ambassador Representative of the Republic of Estonia, Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, CH-1209 Genève, Switzerland H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of Estonia, Frederiksgade 19, 4th floor, 1265 Copenhagen K, Denmark Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn, Estonia

– 3 –

UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email: [email protected] DK-2100 Copenhagen Ø Denmark

Fax: +45 45 33 70 01 Website: https://www.who.int/europe

WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ

WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

Date: 31 May 2024 Ms Helen Sõber Adviser European Union Affairs and International Co- operation Department Ministry of Social Affairs Suur-Ameerika 1 10122 Tallinn Estonia

REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L’EUROPE

REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Head office:

UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark

Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01 Email: [email protected]

Website: https://www.who.int/europe

Our reference: Notre référence: Unser Zeichen: См. наш номер:

Your reference: Votre référence: Ihr Zeichen: На Ваш номер:

Dear Ms Sõber,

Assessing progress towards the global diabetes targets in the WHO European region

I have the honour to inform you that the WHO Regional Office for Europe has started the above- mentioned initiative, which includes a number of meetings. Diabetes is one of the most common chronic conditions in Europe. At least 64 million adults and around 300 000 children and adolescents are estimated to be living with diabetes in the WHO European Region. Furthermore, according to International Diabetes Federation estimates, one third remains undiagnosed and up to half may not meet their treatment targets. Five global diabetes coverage targets were adopted at the seventy-fifth World Health Assembly (WHA), which were developed following the seventy-fourth WHA resolution 74.4 on reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. The five new targets set the standard that, by 2030: 80% of people with diabetes are diagnosed; 80% of people with diagnosed diabetes have good control of glycaemia; 80% of people with diagnosed diabetes have good control of blood pressure; 60% of people with diabetes of 40 years or older receive statins; and 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring. The targets complement the wider noncommunicable disease agenda, supporting achievement of the 2030 Agenda for Sustainable Development, and the global and European action plans for the prevention and control of noncommunicable diseases. Additionally, the targets specifically support the 2021 WHO Global Diabetes Compact initiative. However, there is currently not a clear picture of progress against the diabetes targets in the WHO European Region, and possibly also at national level. To support Member States, WHO Regional Office for Europe is launching an initiative to get a more robust assessment of progress against the global diabetes targets in the WHO European Region and in- country. Assessment of the global diabetes targets across the Region can help to support targeted action, reduce disparities, and improve outcomes for those living with diabetes. Further detail on the initiative is available in the attached scope and purpose.

– 2 –

WHO held the first regional online technical workshop on Monday 13th May and you were invited to nominate participants to attend. The workshop aimed to help build a picture of how the targets can be measured within countries, specifically through sharing examples from different national contexts. Follow-up online meetings will be arranged throughout the year to allow as many countries as possible to participate. The second online meeting is scheduled for Tuesday 9th July 2024, and a further one to two meetings to follow by the end of 2024. The working languages will be English and Russian, and simultaneous interpretation will be provided. As we did not already hear from you, we wonder if you would still be interested to provide nominations of two participants for this initiative and the related meetings. You may wish to consider the following as participants:

 Leaders working in diabetes, such as chief endocrinologists or heads of national diabetes programmes;

 Technical experts working in non-communicable disease surveillance, eHealth or diabetes registers.

I would be grateful if you could share the contact details (name, functional title, and email address) of the nominated representatives by 30 June 2024. Please send the nominations by email to Anita Strandsbjerg ([email protected]). For questions about the workshop please contact Dr Jill Farrington, Regional Medical Officer, Cardiovascular Disease and Diabetes ([email protected]). Sincerely yours,

Dr Gauden Galea Strategic Adviser to the Regional Director Special Initiative on NCDs and Innovation Encls: Provisional programme Scope and purpose Copy for information to: Ms Triin Uusberg, Head, European Union Affairs and International Co-operation Department, Ministry of Social Affairs, Suur-Ameerika 1, 10129 Tallinn, Estonia H.E. Ms Riia Salsa-Audiffren, Ambassador Representative of the Republic of Estonia, Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, CH-1209 Genève, Switzerland H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of Estonia, Frederiksgade 19, 4th floor, 1265 Copenhagen K, Denmark Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn, Estonia

– 3 –